Showing results (1381-1390 of 4,882) with videos related to

Sort By:
Pageof 489
Urologic Oncology|January 23, 2016
Effect of minimally invasive radical prostatectomy in older menOluwakayode Adejoro, Priyanka Gupta, Matthew Ziegelmann, et al.
Urologic Oncology|January 23, 2016
The effect of delaying nephrectomy on oncologic outcomes in patients with renal tumors greater than 4cmRoy Mano, Emily A Vertosick, Abraham Ari Hakimi, et al.
Urologic Oncology|January 5, 2016
Asian Americans and prostate cancer: A nationwide population-based analysisGrace F Chao, Nandita Krishna, Ayal A Aizer, et al.
Urologic Oncology|September 21, 2014
Prognostic effect of neuroendocrine differentiation in prostate cancer: A critical reviewCristian I Surcel, Inge M van Oort, Prasanna Sooriakumaran, et al.
Urologic Oncology|September 2, 2014
Molecular profiling of ETS gene rearrangements in patients with prostate cancer registered in REDEEM clinical trialNallasivam Palanisamy, Alexi Tsodikov, Wei Yan, et al.
Urologic Oncology|October 21, 2015
Age-related variation and predictors of long-term quality of life in germ cell tumor survivorsTim J Hartung, Anja Mehnert, Michael Friedrich, et al.
Urologic Oncology|December 10, 2014
Commentary on "Upper tract imaging surveillance is not effective in diagnosing upper tract recurrence in patients followed fornonmuscle invasive bladder cancer." Sternberg IA, Chen LY, Herr HW, Donat SM, Bochner BH, Dalbagni G, Urology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY.: J Urol 2013; 190(4):1187-91. doi:10.1016/j.juro.2013.05.020. [Epub 2013 May 13]Ashish Kamat
Urologic Oncology|November 2, 2015
Future directions in risk stratification and therapy for advanced pediatric genitourinary rhabdomyosarcomaMiriam Harel, Fernando A Ferrer, Linda H Shapiro, et al.
Urologic Oncology|March 28, 2016
Invasion of the urinary collecting system is an independent prognostic factor in pT3 renal cell carcinomaLuyao Chen, Xin Ma, Hongzhao Li, et al.
Urologic Oncology|March 1, 2016
Blocking immune checkpoints in prostate, kidney, and urothelial cancer: An overviewAngela K B Alme, Beerinder S Karir, Bishoy M Faltas, et al.
Pageof 489